Some EU Countries Temporarily Stop Use of AstraZeneca Over Blood Clot Concerns
One day after the Bahamas received 20,000 doses of Astra-Zeneca vaccine, three European countries are temporarily suspending the use of the vaccine while they investigate one death over reports of blood clots.
Denmark, Norway and Iceland said they will pause the use of the vaccine as a precautionary measure for two weeks.
Why it matters
The Bahamas received a batch of AstraZeneca yesterday, the first vaccines to arrive in the country to assist in the fight against COVID-19. The doses were donated by India, which has also helped other Caribbean countries obtain the vaccine.
More AstraZeneca vaccines are expected to arrive in the country in mid-April-May.
The big picture
AstraZeneca has been approved by the World Health Organisation.
What Denmark says
Denmark’s health officials say “it has not been determined, at the time being, that there is a link between the vaccine and the blood clots”.
A 60-year old woman who was inoculated with the vaccine formed a clot and died.
Other reports surfaced that blood clots developed among some people who were vaccinated with AstraZeneca.
Officials are concentrating their investigation on one batch of vaccines those countries received.